Mosharraf H Sarker1, De-En Hu, Paul A Fraser. 1. Cardiovascular Division, King's College London, School of Medicine, Franklin-Wilkins Building, Stamford Street, London, UK.
Abstract
OBJECTIVE: Lysophosphatidic acid (LPA) increases permeability of cerebral endothelium in culture, but it has been suggested that histamine release is required in vivo. METHODS: Cerebral venular permeability was measured by using the single-vessel micro-occlusion technique, and fura-2 ratios were used to track changes in endothelial [Ca(2+)]. RESULTS: Topical acute LPA application dose-dependently increased permeability (log EC(50)-9.4; similar to the K(d) of the LPA1 receptor). The calcium response to LPA was similar to histamine, but the permeability response was unaffected by H(2)-histamine receptor antagonism, and was blocked by Ki16425, a LPA1 receptor antagonist. The permeability response was blocked by nitric oxide synthase and free radical scavenging, which were carried out together, but not separately. Intravascular LPA bolus injection increased permeability. Whole serum albumin, or plasma albumin co-applied with LPA, increased permeability, but less potently than LPA itself (log EC(50) 5.1 and 6.1, respectively). Tachyphylaxis of the LPA1 receptor was demonstrated by LPA application for 10 minutes, which resulted in suppression of the response to subsequent applications for the following 15 minutes. CONCLUSIONS: Lysophosphatidic acid increases cerebrovascular permeability by acting directly on the endothelium and utilizes both nitric oxide and free radical signaling pathways.
OBJECTIVE:Lysophosphatidic acid (LPA) increases permeability of cerebral endothelium in culture, but it has been suggested that histamine release is required in vivo. METHODS: Cerebral venular permeability was measured by using the single-vessel micro-occlusion technique, and fura-2 ratios were used to track changes in endothelial [Ca(2+)]. RESULTS: Topical acute LPA application dose-dependently increased permeability (log EC(50)-9.4; similar to the K(d) of the LPA1 receptor). The calcium response to LPA was similar to histamine, but the permeability response was unaffected by H(2)-histamine receptor antagonism, and was blocked by Ki16425, a LPA1 receptor antagonist. The permeability response was blocked by nitric oxide synthase and free radical scavenging, which were carried out together, but not separately. Intravascular LPA bolus injection increased permeability. Whole serum albumin, or plasma albumin co-applied with LPA, increased permeability, but less potently than LPA itself (log EC(50) 5.1 and 6.1, respectively). Tachyphylaxis of the LPA1 receptor was demonstrated by LPA application for 10 minutes, which resulted in suppression of the response to subsequent applications for the following 15 minutes. CONCLUSIONS:Lysophosphatidic acid increases cerebrovascular permeability by acting directly on the endothelium and utilizes both nitric oxide and free radical signaling pathways.
Authors: Éva Ruisanchez; Péter Dancs; Margit Kerék; Tamás Németh; Bernadett Faragó; Andrea Balogh; Renukadevi Patil; Brett L Jennings; Károly Liliom; Kafait U Malik; Alan V Smrcka; Gabor Tigyi; Zoltán Benyó Journal: FASEB J Date: 2013-11-18 Impact factor: 5.191
Authors: Dawid S Chabowski; Katie E Cohen; Ossama Abu-Hatoum; David D Gutterman; Julie K Freed Journal: Am J Physiol Heart Circ Physiol Date: 2020-04-03 Impact factor: 5.125
Authors: Natalie Hudson; Michael B Powner; Mosharraf H Sarker; Thomas Burgoyne; Matthew Campbell; Zoe K Ockrim; Roberta Martinelli; Clare E Futter; Maria B Grant; Paul A Fraser; David T Shima; John Greenwood; Patric Turowski Journal: Dev Cell Date: 2014-08-28 Impact factor: 12.270